Precision Optics Corporation, Inc.
NASDAQ:POCIMedical - Instruments & Supplies
+$0.14 today
- Market cap
- $53.44M
- Beta
- 0.32
- P/E (TTM)
- -6.9
- EPS (TTM)
- -$0.63
Volume 0.03M
Average 0.05M
POCI Stock-Based Compensation
Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.
Precision Optics Corporation, Inc.NASDAQ: POCI
Stock-Based Compensation · Q3 FY2026 · quarter ended Mar 2026
Stock-based compensation declines year over year
Q3 FY2026 stock-based compensation of $253.78K fell 54.9% year over year, behind the -3.9% change in trailing-twelve-month stock-based compensation. Sequentially, it rose 35.7% from the prior quarter. Over 3 fiscal years it compounded at +16.8% a year.
Context
- Stock-based compensation amounted to 7.6% of revenue in FY2025, up 2.6 pp from a year earlier.
- Stock-based compensation increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -54.9% toward the trailing-twelve-month pace of -3.9%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Stock-Based Compensation history
USD · from the cash flow
- Latest · FY2025
- 1.46M USD
- Year-over-year change
- +52.2%
- 4-year CAGR
- +18.8%
| Period | Period end | Stock-Based Compensation | YoY change |
|---|---|---|---|
| FY2025 | 2025-06-30 | 1.46M | +52.2% |
| FY2024 | 2024-06-30 | 959.78K | +4.4% |
| FY2023 | 2023-06-30 | 919.03K | +0.4% |
| FY2022 | 2022-06-30 | 915.49K | +24.7% |
| FY2021 | 2021-06-30 | 733.93K | — |
Stock-Based Compensation vs competitors
How POCI compares with its peers on the latest reported figures
- POCI's LTM Mar 2026 stock-based compensation of $1.18M is the smallest of the 3 companies compared; the peer median is $2.68M.
- Its year-over-year change of -3.9% is the lowest of 3, against a peer median of +1834.8%.
- Stock-based compensation amounts to 4.1% of revenue for POCI, versus a peer median of 92.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $3.23M | +3574.0% | -47.8% | 179.0% | |
| LTM Mar 2026 | $2.14M | +95.6% | +20.5% | 5.2% | |
| LTM Mar 2026 | $1.18M | -3.9% | +16.8% | 4.1% | |
| Peer median (excluding POCI) | $2.68M | +1834.8% | -13.6% | 92.1% | |
Competitors are the stored peer set for POCI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jun 2021 | FY2022 Jun 2022 | FY2023 Jun 2023 | FY2024 Jun 2024 | FY2025 Jun 2025 |
|---|---|---|---|---|---|
| Net Income | (102.84K) | (928.42K) | (144.61K) | (2.95M) | (5.78M) |
| Depreciation & Amortization | 146.8K | 190.22K | 210.74K | 212.38K | 212.44K |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 733.93K | 915.49K | 919.03K | 959.78K | 1.46M |
| Change in Working Capital | 74.69K | (423.6K) | (364.44K) | (921.31K) | 513.43K |
| Accounts Receivables | (400.25K) | (108.14K) | (1.24M) | 361.92K | (791.24K) |
| Inventory | 311.85K | (680.74K) | 245.93K | (91.88K) | (694.01K) |
| Accounts Payables | 139.14K | 819.28K | 193.09K | (1.03M) | 1.51M |
| Other Working Capital | 23.94K | (454K) | 440.08K | (156.39K) | 486.9K |
| Other Non-Cash Items | (806.03K) | (687.07K) | (701.81K) | 17.5K | 46.57K |
| Operating Cash Flow | 46.55K | (933.37K) | (81.09K) | (2.68M) | (3.55M) |
| Capital Expenditures | (122.4K) | (152.74K) | (52.5K) | (293.88K) | (227.21K) |
| Acquisitions (Net) | (166.67K) | (255.06K) | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | (21.45K) | (6.26K) |
| Investing Cash Flow | (289.06K) | (407.8K) | (52.5K) | (293.88K) | (233.47K) |
| Debt Repayment | (58.8K) | (285.35K) | 341.95K | 443.53K | (1.32M) |
| Common Stock Issued | 28.27K | 1.5M | 2.29M | 12.79K | 6.36M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | (129.38K) | (176.55K) | 12.79K | 111.7K |
| Financing Cash Flow | (30.53K) | 1.09M | 2.45M | 456.32K | 5.15M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (273.05K) | (255.9K) | 2.32M | (2.52M) | 1.37M |
| Free Cash Flow | (75.85K) | (1.09M) | (133.59K) | (2.98M) | (3.77M) |
Precision Optics Corporation, Inc.
NASDAQ:POCI
Intrinsic Alpha fair value
Locked
Current Price
$4.87
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.